Iron Deficiency Injectables Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2023-28

1
Global Iron Deficiency Injectables Market
Research and Forecast Report 2023-2028




Author Elena Anderson Marketing Manager IMARC
Group
2022 IMARC All Rights Reserved
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2
About IMARC Group
Report Description
International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all regions
and industry verticals to identify their
highest-value opportunities, address their most
critical challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Iron Deficiency Injectables Market
Research Report 2023-2028 According to the
latest report by IMARC Group, titled "Iron
Deficiency Injectables Market Global Industry
Trends, Share, Size, Growth, Opportunity and
Forecast 2023-2028," the global iron deficiency
injectables market is expected to exhibit a
growth rate (CAGR) of 12.7 during
2023-2028. Iron deficiency injectables are a
class of intravenous drugs that are administered
in the bloodstream of individuals for treating
iron deficiency. These drugs are directly infused
in the circulatory system as this aids in
building red blood cells (RBCs) in the body more
quickly when compared with oral medications. They
are commonly prescribed to patients with
extremely low levels of iron or in cases that
require fast improvement in the hemoglobin levels
due to their rapid action. Since these
injectables ensure faster absorption of the
infused supplements, they are widely being
prescribed by healthcare professionals in cases
with severe deficiency. These drugs also assist
in minimizing the non-compliance, poor adherence
and adverse gastrointestinal effects that are
often associated with oral drugs. Request for a
PDF sample of this report https//www.imarcgroup.
com/iron-deficiency-injectables-market/requestsamp
le

4
Report Description and Highlights
Report Description
Global Iron Deficiency Injectables Market
Trends The market is primarily driven by the
increasing prevalence of iron deficiency anemia
among the masses, especially women. Since anemia
is often associated with the increased risks of
premature birth and maternal deaths among
pregnant women, iron deficiency injectables are
widely used to treat the same before the
occurrence of medical complications. This has
also led numerous government and non-government
organizations (NGOs) to raise awareness regarding
the adverse effects of anemia among women. These
campaigns aim to promote womens health and
reduce the prevalence of anemia by educating the
masses about the available treatment options.
Such initiatives, in turn, are creating a
positive outlook for the market. Apart from this,
the rising incidences of several chronic
conditions, such as kidney disorders and cancer,
across the globe, along with a considerable
increase in the geriatric population, is
facilitating the uptake of these injectables. The
market is further driven by several technological
advancements in intravenous iron drugs that have
significantly improved the functional capacity of
the injectables and enhanced the restoration of
iron in people suffering from iron deficiency
anemia. Some of the other factors contributing to
the market growth include improving diagnosis
rates, the launch of dextran-free intravenous
formulations and increasing investment in the
healthcare sector. View Report TOC, Figures and
Tables https//www.imarcgroup.com/iron-deficiency
-injectables-market

5
Report Description and Highlights
Report Description

• Key Market Segmentation
• The research report includes the following
  segments
• Breakup by Product Type
• Iron Dextran
• Iron Sucrose
• Ferric Carboxymaltose
• Others
•  
• Breakup by Indication
• Chronic Kidney Disease
• Inflammatory Bowel Disease
• Cancer
• Others
• Breakup by Branded/Generics
• Branded
• Generics

6
Report Description and Highlights
Report Description

•  
• Breakup by Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Breakup by Region
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa
•  

7
Key Questions Answered in the Report
Report Description

• How has the global iron deficiency injectables
  market performed so far and how will it perform
  in the coming years?
• What has been the impact of COVID-19 on the
  global iron deficiency injectables market?
• What are the key regional markets?
• What is the breakup of the market based on the
  product type?
• What is the breakup of the market based on the
  indication?
• What is the breakup of the market based on the
  branded/generics?
• What is the breakup of the market based on the
  distribution channel?
• What are the various stages in the value chain of
  the industry?
• What are the key driving factors and challenges
  in the industry?
• What is the structure of the global iron
  deficiency injectables market and who are the key
  players?
• What is the degree of competition in the
  industry?
•  

8
Table of Contents
Report Description
1    Preface2    Scope and Methodology    2.1
   Objectives of the Study    2.2  
 Stakeholders    2.3    Data Sources       
2.3.1    Primary Sources        2.3.2  
 Secondary Sources    2.4    Market Estimation 
      2.4.1    Bottom-Up Approach        2.4.2  
 Top-Down Approach    2.5    Forecasting
Methodology3    Executive Summary4  
 Introduction    4.1    Overview    4.2    Key
Industry Trends5    Global Iron Deficiency
Injectables Market    5.1    Market Overview   
5.2    Market Performance    5.3    Impact of
COVID-19    5.4    Market Forecast

9
Table of Contents
Report Description
6    Market Breakup by Product Type    6.1  
 Iron Dextran        6.1.1 Market Trends       
6.1.2 Market Forecast    6.2    Iron Sucrose   
    6.2.1 Market Trends        6.2.2 Market
Forecast    6.3    Ferric Carboxymaltose       
6.3.1 Market Trends        6.3.2 Market
Forecast    6.4    Others        6.4.1 Market
Trends        6.4.2 Market Forecast 7    Market
Breakup by Indication    7.1     Chronic Kidney
Disease        7.1.1 Market Trends        7.1.2
Market Forecast          Click here to visit
the complete table of content with list of
figures and tables https//www.imarcgroup.com/iro
n-deficiency-injectables-market/toc

10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
12
Report Description and Highlights
Report Description

2022 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
13

Contact Us